Medicofarma Biotech Statistics

Total Valuation

Medicofarma Biotech has a market cap or net worth of PLN 24.88 million. The enterprise value is 26.77 million.

Market Cap	24.88M
Enterprise Value	26.77M

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Medicofarma Biotech has 67.98 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	67.98M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	10.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.30
PB Ratio	3.18
P/TBV Ratio	3.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.45
EV / Sales	25.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-58.39

Financial Position

The company has a current ratio of 0.83, with a Debt / Equity ratio of 0.24.

Current Ratio	0.83
Quick Ratio	0.83
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	-4.12
Interest Coverage	-16.99

Financial Efficiency

Return on equity (ROE) is -33.70% and return on invested capital (ROIC) is -14.45%.

Return on Equity (ROE)	-33.70%
Return on Assets (ROA)	-9.84%
Return on Capital (ROIC)	-14.45%
Revenue Per Employee	53,386
Profits Per Employee	-158,368
Employee Count	20
Asset Turnover	0.07
Inventory Turnover	528.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.71% in the last 52 weeks. The beta is 3.20, so Medicofarma Biotech's price volatility has been higher than the market average.

Beta (5Y)	3.20
52-Week Price Change	-60.71%
50-Day Moving Average	0.40
200-Day Moving Average	0.59
Relative Strength Index (RSI)	39.02
Average Volume (20 Days)	26,013

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicofarma Biotech had revenue of PLN 1.07 million and -3.17 million in losses. Loss per share was -0.05.

Revenue	1.07M
Gross Profit	-296,637
Operating Income	-2.39M
Pretax Income	-3.38M
Net Income	-3.17M
EBITDA	-657,811
EBIT	-2.39M
Loss Per Share	-0.05

Full Income Statement

Balance Sheet

The company has 1,593 in cash and 1.89 million in debt, giving a net cash position of -1.89 million or -0.03 per share.

Cash & Cash Equivalents	1,593
Total Debt	1.89M
Net Cash	-1.89M
Net Cash Per Share	-0.03
Equity (Book Value)	7.81M
Book Value Per Share	0.11
Working Capital	-698,114

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -92,894 and capital expenditures -365,606, giving a free cash flow of -458,500.

Operating Cash Flow	-92,894
Capital Expenditures	-365,606
Free Cash Flow	-458,500
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is -27.78%, with operating and profit margins of -224.00% and -296.65%.

Gross Margin	-27.78%
Operating Margin	-224.00%
Pretax Margin	-316.55%
Profit Margin	-296.65%
EBITDA Margin	-61.61%
EBIT Margin	-224.00%
FCF Margin	n/a

Dividends & Yields

Medicofarma Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-12.73%
FCF Yield	-1.84%

Stock Splits

The last stock split was on November 8, 2011. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 8, 2011
Split Type	Reverse
Split Ratio	0.1

Scores

Medicofarma Biotech has an Altman Z-Score of 3.92.

Altman Z-Score	3.92
Piotroski F-Score	n/a